TANG CAPITAL PARTNERS LP 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
TANG CAPITAL PARTNERS LP | 87,594 3.000% |
-25,062 (-22.25%) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
TANG CAPITAL PARTNERS LP | 112,656 7.100% |
18,300 (+19.39%) |
Filing |
| 2022-12-27 5:06 pm Purchase |
2022-12-16 | 13G | Aligos Therapeutics, Inc. ALGS |
TANG CAPITAL PARTNERS LP | 94,356 5.900% |
94,356 (New Position) |
Filing |